LOC110806263
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
With the recent discovery of recurrent mutations in the TERT promoter in melanoma, identification of other somatic causal promoter mutations is of considerable interest.
|
26082173 |
2015 |
LOC110806263
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A total of 77% of areas of intermediate lesions and melanomas in situ harbored TERT promoter mutations, a finding that indicates that these mutations are selected at an unexpectedly early stage of the neoplastic progression.
|
26559571 |
2015 |
LOC110806263
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
TERT promoter mutations in sinonasal malignant melanoma: a study of 49 cases.
|
25746036 |
2015 |
LOC110806263
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness.
|
26055532 |
2015 |
LOC110806263
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In this review we discuss the discovery and possible implications of the TERT promoter mutations in melanoma and other cancers.
|
24657534 |
2014 |
LOC110806263
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The aim of this study was to test the hypothesis that MUP and mucosal melanomas harbor different prevalences of TERT-promoter mutations.
|
24463461 |
2014 |
LOC110806263
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
TERT promoter mutations were identified in 154 (43%) of 362 successfully sequenced melanomas.
|
25217772 |
2014 |
LOC110806263
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Our results suggest that various carcinogenic factors may cause distinct TERT promoter mutations in BCC and that TERT promoter mutations might be associated with a poorer prognosis in melanoma.
|
24691053 |
2014 |
LOC110806263
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We found that the activating TERT promoter mutations reported in melanoma are also frequent in squamous cell carcinoma (50%) and basal cell carcinoma, the latter including both sporadic tumors (78%) and tumors from patients with nevoid basal cell carcinoma syndrome (68%).
|
24030752 |
2014 |
LOC110806263
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations of the TERT promoter were not identified in conjunctival nevi or PAM without atypia, but were detected in 2/25 (8%) of PAM with atypia and 16/39 (41%) of conjunctival melanomas.
|
25159205 |
2014 |
LOC110806263
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The rarity of TERT promoter mutation in the acral lentiginous melanoma was consistent with the supposed role of UV light in the melanoma pathogenesis and also corroborated the view that acral lentiginous melanomas have a different pathogenesis with the melanomas from sun-exposed sites.
|
24588324 |
2014 |
LOC110806263
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In melanoma a correlation has been suggested between the occurrence of TERT promoter mutations and v-RAF murine sarcoma viral oncogene homolog B1 (BRAF) mutations.
|
25035100 |
2014 |
LOC110806263
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Recently, frequent somatic mutations in the TERT promoter have been described in several tumor entities such as melanoma, glioblastoma, bladder cancer, and hepatocellular carcinoma.
|
25267585 |
2014 |
LOC110806263
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations of TERT promoter with UV signatures are frequent in conjunctival melanomas and favour a pathogenetic kinship with cutaneous melanomas.
|
23799844 |
2013 |
LOC110806263
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
TERT promoter mutations in cutaneous melanoma often show UV-signatures.
|
24260374 |
2013 |
LOC110806263
|
0.100 |
Biomarker
|
disease |
BEFREE |
We then screened the TERT promoter in sporadic melanoma and observed recurrent ultraviolet signature somatic mutations in 125 of 168 (74%) of human cell lines derived from metastatic melanomas, 45 of 53 corresponding metastatic tumor tissues (85%), and 25 of 77 (33%) primary melanomas.
|
23348503 |
2013 |
LOC110806263
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Highly recurrent TERT promoter mutations in human melanoma.
|
23348506 |
2013 |
LOC110806263
|
0.100 |
Biomarker
|
disease |
BEFREE |
These results indicate that AdRGD combined with transcriptional regulation using Tyr or TERT promoter is a potentially useful and safe vector system for suicide gene therapy for melanoma.
|
15746944 |
2005 |